Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global bacterial disease diagnostics market was valued at USD 3.1 billion in 2023 due to the rising prevalence of bacterial infections across the globe. The market is expected to grow at a CAGR of 7.10% during the forecast period 2024-2032 and attain a market value of USD 5.8 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Bacterial disease diagnostics are used to detect and identify bacterial pathogens in clinical samples to determine the presence and type of infection. Healthcare providers use a variety of methods for precise diagnosis and treatment decisions. The method for diagnosing bacterial diseases includes taking samples from patients and using methods such as bacterial culture, biochemical tests, DNA amplification through PCR, and serological tests for antibodies/antigens. Imaging techniques like X-rays or CT scans have the capability to determine the level of infections in organs such as the lungs.
Bacterial diseases are caused by pathogenic bacteria, which can impact various areas of the body. It includes infections such as respiratory infections such as tuberculosis, gastrointestinal infections like Salmonella, skin infections like Staphylococcus, and sexually transmitted infections such as gonorrhoea. It can vary from slight ailments to serious diseases such as meningitis and septicemia which require immediate medical attention.
Surge in Prevalence of Bacterial Infections Spurs Market Growth
The market growth can be attributed to the growing incidence of illnesses such as tuberculosis, salmonella, staphylococcus, gonorrhoea, bacterial pneumonia, and urinary tract infections. According to the World Health Organization, Tuberculosis (TB) remains one of the most fatal diseases globally, despite being preventable and treatable. Annually, TB affects around 10 million individuals globally and causes around 1.5 million deaths annually, establishing it as the deadliest infectious disease worldwide.
Population growth, urbanization, and antibiotic-resistant bacteria strains are fueling the demand for sophisticated diagnostic tools. Enhancing diagnostic capabilities, such as molecular diagnostics and point-of-care testing, is essential for quickly identifying bacterial pathogens for effective treatment.
Technological Advancements to Boost Global Bacterial Disease Diagnostics Market Demand
Technological progress such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) are driving the market growth. NGS allows thorough examination of bacterial genomes to precisely identify pathogens. PCR particularly identifies bacterial DNA and decreases the time it takes to make a diagnosis. AI and machine learning enhance data analysis for bacterial infections. In December 2022, Stanford Medicine researchers created a new blood test that can effectively differentiate between bacterial and viral infections, adhering to World Health Organization guidelines. In June 2024, a Dutch scientist was nominated as a finalist for the Young Inventors Prize for developing a portable AI-driven testing tool to diagnose bacterial infections. Slow diagnosis of common bacterial infections causes a significant number of deaths globally. The goal is to enhance treatment decisions through rapid AI detection.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Growing Awareness Around Early Diagnosis
Rising knowledge about bacterial infections is driving the expansion of the bacterial disease diagnostics market. Efforts to promote public health focus on early identification and prevention, particularly in countries with low to moderate incomes. The public is increasingly concerned due to media attention on outbreaks and antibiotic resistance, leading to a higher need for trustworthy diagnostic tools. Non-profit organizations and health organizations are informing communities about the benefits of diagnostics, leading to a more informed population that actively seeks medical assistance, supporting the progress and use of sophisticated diagnostic techniques.
Government Initiatives and Funding
The government is encouraging collaboration between public and private sectors for the introduction of new products. Financial funding and grants help in the introduction of products to the market, improving diagnostic capabilities and public confidence in healthcare systems.
Impact of COVID-19
The pandemic has had a significant impact on the market. It also emphasises the requirement for advanced testing solutions. The pandemic emphasized the necessity of rapid, accurate, and available diagnostics, transforming bacterial disease detection. Growing focus on infection prevention and prompt identification is driving the need for bacterial examinations.
Demand for Early Diagnosis
Early diagnosis is important for successful management of bacterial infections and for averting potential complications. Enhancements in diagnostic tools make it simpler and enhance patient results. Point-of-care testing tools offer instant outcomes, assisting in quick medical judgments. Further, public health programs aim to increase early detection by raising awareness and implementing screening programs, which drive advancements and funding for bacterial disease testing.
Market Breakup by Disease
Market Breakup by Product
Market Breakup by Method
Market Breakup by End User
Market Breakup by Region
Segmentation Based on Disease to Witness Substantial Growth
Based on disease, the market is segmented into respiratory, gastrointestinal, genitourinary, skin and soft tissue, systemic, and others. Among them, respiratory disease diagnosis is expected to lead the market.
Respiratory diagnostics are expected to lead due to the widespread presence of diseases such as tuberculosis and pneumonia. These illnesses present a substantial risk to global health, leading to severe sickness and fatalities. The increasing number of respiratory infections in developing countries without access to clean air and healthcare is driving the demand for precise diagnostic methods.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to dominate the market with its advanced healthcare infrastructure, high expenditure, and widespread infections. Government efforts and regulations continue to drive market expansion through their backing of healthcare advancements and early detection of diseases.
Europe is also poised to have a significant market share driven by its robust healthcare systems, understanding of bacterial infections, and expanding elderly population. Market growth is boosted by a focus on technology and improved access to healthcare. The market in the Asia-Pacific region is rapidly expanding due to the vast population and rising bacterial infection prevalence. The key factors that are driving the market in this region include an emphasis on early disease detection and improving healthcare infrastructure.
The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as strategic initiatives including recent partnerships and collaborations by the leading players. The major companies in the market are as follows:
Cepheid Inc. (a Danaher company)
Cepheid is a division of Danaher Corporation that focuses on automating nucleic acid tests for the detection of pathogens and genetic disorders. It was established in 1996 and has its headquarters in California, United States. In April 2023, the company revealed the plan to launch new tests for infectious diseases like tuberculosis and respiratory viruses.
F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche also known as Roche is a multinational healthcare company based in Switzerland. It was established in Basel in 1896. The company operates in pharmaceuticals and diagnostics, with a focus on scientific excellence in the discovery and development of medicines and diagnostics.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a US-based corporation focused on life science and clinical research. It provides worldwide analytical tools, clinical research solutions, specialized diagnostic products, lab services, and pharmaceutical and biotech offerings. It was established in 1956 and headquartered in Massachusetts, United States.
Abbott Laboratories
Abbott Laboratories identifies, creates, produces, and markets a wide range of healthcare goods and services. The corporation's offerings consist of medications, supplements, medical tests, and vascular items. It was established in 1888 and having its headquarters in Illinois, USA.
Other players in the market are Becton, Dickinson and Company, bioMerieux, Inc., Bio-Rad Laboratories, Inc., Hologic, Inc., and Siemens Healthineers AG.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Disease |
|
Breakup by Product |
|
Breakup by Method |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share